The table below is a review of notable updates that occurred in November 2024 for investigational products in development (not an inclusive list). Click on the status to view our full coverage.

About 3.5 million persons used PrEP in 2023 globally, which was far below the goal of 21.2 million set for 2025 ...

(HealthDay News) — Discontinuing cholinesterase inhibitors upon memantine initiation is not associated with an increased risk for long-term care institutionalization among older adults with dementia, ...

Tumor HI is a rare condition that results in hypoglycemia caused by either islet cell tumors (eg, insulinomas) or non-islet cell tumors (eg, hepatocellular carcinoma).

Most common exclusion criteria were major depressive disorder, malignant neoplasms, liver disease, uncontrolled HTN ...

Three good practice statements include regularly testing serum iron studies, which can influence decision to use oral or IV iron treatment ...